PT-141 is a constrained cyclic peptide, and confirming a lot's sequence, cyclization, and purity is the analytical starting point for melanocortin-receptor research.
Reversed-phase HPLC
HPLC resolves correctly formed PT-141 from linear intermediate and other synthesis-related byproducts, with the resulting purity figure interpreted per understanding HPLC purity.
Mass spectrometry for identity
Because PT-141 is derived from the melanotan-II scaffold, mass spectrometry is important for confirming a lot is genuinely the more MC4R-selective PT-141 sequence rather than the broader-acting melanotan-II parent compound — see HPLC vs. mass spectrometry.
Why receptor selectivity depends on verified identity
PT-141's research value as a probe for central MC4R signaling (see its mechanism of action) depends on it being the correct, distinct compound — misidentification against its parent scaffold would compromise any selectivity-based comparison.
Documentation to expect
A lot-specific certificate of analysis with HPLC purity and mass-spec identity — see how to read a CoA.
Product page: PT-141 research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.